What’s new in SyMAP 2.0
One connected platform.
Continually advancing.
Global pricing keeps moving. SyMAP is updated monthly, developing the modelling, forecasting and optimisation capabilities your next decision depends on.
Illustrative pricing connections using configured reference baskets and reviewed Middle Eastern, African and Asia-Pacific benchmarks. International markets feed the US MFN and GENEROUS benchmarks. IRP events connect the Netherlands, Greece, Portugal, France, Japan, Canada, Brazil, Morocco, Saudi Arabia, the UAE, the Philippines and Taiwan; dotted links show Italy’s informal referencing and South Africa’s international benchmarking. Morocco shows its six fixed reference countries; an additional country-of-origin reference depends on the product. The Philippines illustrates reference baskets used for selected medicines under price caps; Taiwan illustrates its ten-market reimbursement reference basket. Assessments continue when their destination is beyond view, with visible reference-market flows travelling towards the horizon. Markets beyond the horizon remain in each basket. Animation timing is illustrative, not a calendar of national assessments. No real product prices are displayed.
- SyMAP Event Feed:
SyMAP 2.0 · Continually advancing
From pricing simulation
to global strategy.
SyMAP 2.0 connects the questions that shape a product’s commercial future: international prices, US policy exposure, patient demand, global revenue and the alternatives worth exploring.
One product dataset.
More connected decisions.
Build a reusable foundation in Data Hub. Model the scenario. Inspect the result. Keep developing the product outlook as the evidence and the landscape change.
Updated monthlyOngoing development across modelling, forecasting and optimisation.
One dataset. A connected forecast.
Bring the whole product
into the picture.
The integrated forecast brings together international price evolution, US policy effects and monthly demand. Patient models connect population and treatment assumptions to the volume forecast that underpins revenue.
Reusable foundations
Start in Data Hub.
Store product and market inputs, use shared libraries for rules, patient models and FX, and keep saved runs available to review and compare.
Explore Data HubFrom patients to revenue
See what drives demand.
Model eligible populations, competitive uptake and persistence by indication. Connect the resulting product demand with price paths, rebates and launch timing.
Explore patient & revenue forecastingA dataset that develops with the product
- Early planningBuild the initial assumptions
- LaunchRefine prices, timing and demand
- LifecycleExplore indications and evolving markets
Optimizer Studio
Explore the complete plan.
Understand the trade-offs.
Pricing and launch studies evaluate alternatives against your chosen objective. Launch-sequence search brings the selected IRP, MFN and revenue effects together, moving from broader timing choices towards finer launch dates.
Search the choices
Explore price ranges, launch timing, corridors, targets and combinations of commercial levers.
Inspect the contribution
Compare your original plan with the best evaluated alternative and examine the drivers of the revenue difference.
Revisit the strategy
Replay an earlier strategy against updated assumptions to see whether the result still supports the decision.
Inspect the result Deeper analysis across connected capabilities
Make the assumptions explicit.
Make the alternatives comparable.
US MFN modelling
Compare policy and agreement choices.
Configure voluntary-agreement timing, product pathways and channel scope. Compare with baseline and CMS-model scenarios, with tariff assumptions where relevant to the study.
Explore US MFN modellingInternational reference pricing
Inspect the rules and thresholds.
Custom formulas, comparison views and sensitivity analysis support closer examination of the baskets, timing and price changes that shape international outcomes.
Explore international reference pricingGLOBE final rule modelling
SyMAP now incorporates the GLOBE final rule’s timing, international benchmarks and additional Part B rebate calculations.
- Choose which drugs to assess and set their entry, exit and coverage assumptions.
- Inspect Method I and quarterly Method II benchmarks, including GDP purchasing-power adjustments.
- Review additional rebates above the Part B inflation rebate and their effect on forecast revenue.
- Test a hypothetical extension beyond the initial period, with your own duration and coverage assumptions.
Compare pricing and launch plans, assess exposure after GENEROUS or model a permitted withdrawal using the relevant agreement terms. When updating an existing forecast, review its saved entry and exit settings before running it again.
Built around your team’s work
From the first import
to the next review.
Keep the modelling workflow connected to the way your team prepares data, shares assumptions and explains decisions.
Bring data into the workflow
Import supported spreadsheets, or connect existing models to SyMAP simulations through the API. Reuse saved datasets across compatible tools.
Share the foundation
Shared datasets and libraries, role-based access, multi-factor sign-in and organisation branding support a consistent team workspace.
Keep the reasoning visible
Saved runs, comparison and AI-assisted analysis help explain results. Governed AI actions require confirmation and retain an audit trail.
Monthly product development extends the capabilities your team uses to respond to changing pricing and market-access questions.
Explore the integrated platformThe product story
How the platform developed.
SyMAP 2.0 launched in August 2026. The capabilities above reflect its continuing development.
Explore the original announcements
Your next decision
See what SyMAP 2.0
could change for your team.
Explore the current platform in a demo built around your products, markets and decisions.